Press Release

Veterinary Clostridium Vaccine Market 2019 Size, Trends, Share, Leading Company – Forecast to 2026

Veterinary Clostridium Vaccine Market report covers top players as MSD Animal Health Bimeda, Inc. Bayer AG Zoetis Services LLC Ceva Bimeda, Inc. Boehringer Ingelheim International GmbH and Other key players

According to the United States Department of Agriculture (USDA), in the year 2016, the cattle population was around 92 million. Amongst them, a considerable number of cattle was prone to clostridial diseases. Fortune Business Insights, in an upcoming report, titled, “Veterinary Clostridium Vaccine Market Size, Share and Global Trend By Animal (Ovine, Bovine, Equine, Porcine, Poultry, Others), By Distribution Channel (Veterinary Hospitals & Clinics, Retail Pharmacies, Online Pharmacies, Veterinary Research Institutes, Others), and Geography Forecast till 2026,” states that increasing demand for meat and animal-based products is projected to boost the global veterinary clostridium vaccine market growth in the forthcoming years.

Get Sample PDF Brochure at

Fortune Business Insights lists out a few of the prominent market players operating in the global veterinary clostridium vaccine market. They are:

  • MSD Animal Health
  • Bimeda, Inc.
  • Bayer AG
  • Zoetis Services LLC
  • Ceva
  • Bimeda, Inc.
  • Boehringer Ingelheim International GmbH
  • Virbac
  • Elanco
  • Other market players

The report offers present and future outlook of the global veterinary clostridium vaccine market in the emerging as well as developed regions. It further provides segment-wise information for better understanding of each segment and their dominant sub-segments. All segments provided in the report are represented at the country level. The report also covers in-depth analysis of various aspects, namely, growth drivers, key developments, competitive landscape, and obstacles.

Increasing Demand for Porcine-based Products to Propel the Porcine Sub-segment

In terms of animal, the global veterinary clostridium vaccine market is categorized into poultry, porcine, ovine, equine, bovine, and others. Amongst these, the porcine sub-segment is projected to hold notable global market share. It is likely to occur due to a rise in the demand for porcine-based products as well as the increasing incidence of zoonotic diseases.

Browse Complete Report Details at

Increasing Awareness Programs Regarding Animal Welfare to Favor Growth in Asia Pacific

Geographically, the global veterinary clostridium vaccine market is divided into Asia Pacific, the Middle East and Africa, North America, Europe, and Latin America. Out of these regions, North America is leading the global veterinary clostridium vaccine market owing to the increasing prevalence of clostridial diseases in the region. Moreover, a high rate of fatality of the disease, increasing number of clinics and hospitals, and rising rates of livestock are expected to contribute to the market growth.

Combined with this, growing number of veterinarians and increasing consumption of animal-based products, such as meat will propel the market in this region. Asia Pacific, on the other hand, is considered to be one of the fastest-growing markets due to a rise in the awareness programs regarding animal welfare and increasing government initiatives. Furthermore, large pool of livestock and rising incidence of clostridial diseases will impact the veterinary clostridium vaccine market in this region positively.


By Animal

  • Ovine
  • Bovine
  • Equine
  • Porcine
  • Poultry
  • Others

By Distribution Channel

  • Veterinary Hospitals & Clinics
  • Retail Pharmacies
  • Online Pharmacies
  • Veterinary Research Institutes
  • Others

By Geography

Merc Collaborates with Rapid Genomics to Gain Exclusive Rights to its Viral Flex-Seq

Merck Animal Health, a leading manufacturer of veterinary medicines, headquartered in the U.S., partnered up with Rapid Genomics, a DNA genotyping and genetic data analysis company in February 2019. The agreement would enable Rapid Genomics to grant Merck rights to its vaccination verification tool called Viral Flex-Seq. The tool would be used in combination with Merck Animal Health’s Innovax vaccines.

It would also include Innovax-ND-IBD, an innovative vaccine that protects against three infectious poultry diseases, namely, Marek’s Disease (MD), Infectious Bursal Disease (IBD), and Newcastle Disease (ND) in a single dose. Viral Flex-Seq includes the next-generation sequencing technology to detect copies of Innovax vaccines and separate them from the field viruses. It also provides highly-accurate and sensitive result to confirm the presence of replication in birds.


What is the market size and growth rate of the global and regional market by various segments?

What is the market size and growth rate of the market for selective countries?

Which region or sub-segment is expected to drive the market in the forecast period?

What Factors are estimated to drive and restrain the market growth?

What are the key technological and market trends shaping the market?

What are the key opportunities in the market?

What are the key companies operating in the market?

Which company accounted for the highest market share?

Why Choose Fortune Business Insights?

More Trending Topics from Fortune Business Insights:

High-intensity Focused Ultrasound System Market 2019 to 2024 With Top Countries Data : Opportunities, Industry Trends and Policies by Regions and Companies

Global Allergy Immunotherapy Market to Gain from a Rise in Population Reported Worldwide


Jesus Rust

Jesus is leading the environment column. He is a very renowned environmentalist and has worked in many projects, some of which are based in faraway lands too. He always encourages environment conservation and sometimes keeps small group talks about the concerns. His writing and editing skills act the cheery on the top of the cake.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *